标准、规范、准则_EPA Method 1671 Volatile Organic Compounds Specific to the Pharmaceutical Manufacturing Industry by GC_FID.pdf

Method 1671 Volatile Organic Compounds Specific to the Pharmaceutical Manufacturing Industry by GC/FID Revision A, July 1998 Method 1671, Revision A Volatile Organic Compounds Specific to the Pharmaceutical Manufacturing Industry by GC/FID 1.0 Scope and Application 1.1 This method is for surveying and monitoring under the Clean Water Act. The method is used to determine certain non-purgeable volatile organic pollutants specific to the pharmaceutical manufacturing industry (PMI) that are amenable to direct aqueous injection gas chromatography (GC) and detection by a flame ionization detector (FID). 1.2 The PMI analytes listed in Table 1 may be determined in waters, soils, and municipal sludges by this method. 1.3 The detection limits of Method 1671 are usually dependent on the level of interferences rather than instrumental limitations. The minimum levels (MLs) in Table 2 are the level that can be attained with no interferences present. 1.4 This method is recommended for use by, or under the supervision of, analysts experienced in the operation of gas chromatographs and in the interpretation of chromatograms. 1.5 This method is performance-based. The analyst is permitted to modify the method to overcome interferences or to lower the cost of measurements, provided that all performance criteria in this method are met. The requirements for establishing method equivalency are given in Section 9.2. 2.0 Summary of the Method 2.1 The percent solids content of the sample is determined. If the solids content is less than 1%, an internal standard(s) is added to a